Magnitude and timing of the antiviral response determine SARS-CoV-2 replication early in infection
Nagarjuna R. Cheemarla, Timothy A. Watkins, Valia T. Mihaylova, Bao Wang, Dejian Zhao, Guilin Wang, Marie L. Landry, View ORCID ProfileEllen F. Foxman
doi: https://doi.org/10.1101/2021.01.22.21249812
Nagarjuna R. Cheemarla
1Department of Laboratory Medicine, Yale School of Medicine, New Haven CT, U.S.A. 06520
Timothy A. Watkins
1Department of Laboratory Medicine, Yale School of Medicine, New Haven CT, U.S.A. 06520
2Department of Immunobiology, Yale School of Medicine, New Haven CT, U.S.A. 06520
Valia T. Mihaylova
1Department of Laboratory Medicine, Yale School of Medicine, New Haven CT, U.S.A. 06520
Bao Wang
1Department of Laboratory Medicine, Yale School of Medicine, New Haven CT, U.S.A. 06520
2Department of Immunobiology, Yale School of Medicine, New Haven CT, U.S.A. 06520
Dejian Zhao
3Department of Genetics, Yale School of Medicine, New Haven CT, U.S.A. 06520
4Yale Center for Genomic Analysis, Yale School of Medicine, New Haven CT, U.S.A. 06520
Guilin Wang
3Department of Genetics, Yale School of Medicine, New Haven CT, U.S.A. 06520
4Yale Center for Genomic Analysis, Yale School of Medicine, New Haven CT, U.S.A. 06520
Marie L. Landry
1Department of Laboratory Medicine, Yale School of Medicine, New Haven CT, U.S.A. 06520
5Department of Internal Medicine, Yale School of Medicine, New Haven CT, U.S.A. 06520
Ellen F. Foxman
1Department of Laboratory Medicine, Yale School of Medicine, New Haven CT, U.S.A. 06520
2Department of Immunobiology, Yale School of Medicine, New Haven CT, U.S.A. 06520
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Cheemarla et al 2021 Supplement[supplements/249812_file02.pdf]
Posted January 26, 2021.
Magnitude and timing of the antiviral response determine SARS-CoV-2 replication early in infection
Nagarjuna R. Cheemarla, Timothy A. Watkins, Valia T. Mihaylova, Bao Wang, Dejian Zhao, Guilin Wang, Marie L. Landry, Ellen F. Foxman
medRxiv 2021.01.22.21249812; doi: https://doi.org/10.1101/2021.01.22.21249812
Magnitude and timing of the antiviral response determine SARS-CoV-2 replication early in infection
Nagarjuna R. Cheemarla, Timothy A. Watkins, Valia T. Mihaylova, Bao Wang, Dejian Zhao, Guilin Wang, Marie L. Landry, Ellen F. Foxman
medRxiv 2021.01.22.21249812; doi: https://doi.org/10.1101/2021.01.22.21249812
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)